Mcl‐1 and Bcl‐x<sub>L </sub> are co‐regulated by IL‐6 in human myeloma cells

Denis Puthier, Sophie Derenne, Sophie Barillé‐Nion, Philippe Moreau, Jean‐Luc Harousseau, Régis Bataille, Martine Amiot

British Journal of Haematology · 1999 · 153 citations · 11 references

Concepts

Abstract

Multiple myeloma (MM) is a slowly proliferative malignancy in which malignant plasma cells accumulate within the bone marrow. The expression of several anti-apoptotic proteins was evaluated by immunoblotting in human myeloma cell lines and in highly purified native myeloma cells. Expression of Bcl-xL, Mcl-1 and Bcl-2 was found in most of the samples; expression of Bcl-xL and Mcl-1 seemed to be related on myeloma cells. In a system of apoptosis by growth factor deprivation on myeloma cells, we showed that the effect of Bcl-2 seemed minimal whereas Mcl-1 and Bcl-xL were tightly regulated by interleukin (IL)-6. These findings underline the important role of Mcl-1 and Bcl-xL instead of Bcl-2 in IL-6-induced survival of myeloma cells.

References

11